Calton & Associates’s Incyte INCY Stock Holding History

Calton & Associates’s Portfolio INCY Stock Details INCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-53	Closed	-$5K	–	799
2017 Q4	$5K	Buy	+53	New	+$5.54K	﹤0.01%	1250

Other funds holding INCY

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

Calton & Associates's INCY Position: Q1 2018 in Review

Calton & Associates sold out of Incyte (INCY) in Q1 2018, closing a stake of 53 shares — an estimated $5K sold.

Calton & Associates first reported a position in INCY in Q4 2017 and held it in 1 quarter. The position peaked at $5K in Q4 2017. 499 funds tracked by Wall St. Rank hold INCY as of Q1 2018.

Calton & Associates reported no remaining Incyte position as of Q1 2018 after selling out during the quarter.
Calton & Associates sold 53 Incyte shares in Q1 2018, an estimated $5K.
Calton & Associates first reported a position in Incyte in Q4 2017 and held it in 1 quarter.
Calton & Associates's Incyte position peaked at $5K in Q4 2017.
499 funds tracked by Wall St. Rank held Incyte as of Q1 2018.

Based on Calton & Associates's 13F filing for Q1 2018, filed 17 Apr 2018.